Interventional Pain Management: A Practice-Management Q&A

Billing · Coding · Compliance · Contracting · Credentialing · Behavioral Health · Ambulatory Surgery Centers
Interventional pain management sits at the intersection of high procedural volume, tight payer scrutiny, and rapidly shifting coverage rules. The questions below address the operational, financial, and regulatory issues that determine whether a pain practice or ASC gets paid cleanly, stays compliant, and grows sustainably.

A note on codes and coverage: CPT/HCPCS codes, Medicare LCDs, frequency limits, and fee schedules change annually and vary by payer and jurisdiction. Treat the specifics below as a working framework, and verify current-year values against your MAC's active LCDs, the CMS fee schedules, and each payer's medical policy before billing.

BILLING

Q: What place-of-service (POS) codes matter most in interventional pain, and why do they change reimbursement?
The three that drive most pain billing are POS 11 (office), POS 22 (on-campus hospital outpatient), and POS 24 (ambulatory surgery center). The same injection can pay very differently depending on where it's performed. In the office, the practice bills a single global fee that includes the physician work and the practice expense (the facility component is baked in). In an ASC or HOPD, the physician bills only the professional component while the facility bills separately for its own services. Using the wrong POS is one of the most common causes of denials and take-backs, because it changes both the expected fee and the medical-necessity expectations the payer applies.

Q: When is prior authorization required, and how should a pain practice manage it?
Increasingly, the answer is "for almost everything interventional." Epidural steroid injections, facet interventions, radiofrequency ablation, spinal cord stimulator trials and implants, and vertebral augmentation are common prior-auth targets across commercial and Medicare Advantage plans. The safest operational posture is a dedicated authorization workflow that: confirms the specific CPT codes and levels to be performed, documents conservative-care history and imaging up front, obtains the auth before scheduling, and re-verifies that the authorized codes match what's actually performed. A mismatch between the authorized level or laterality and the billed claim is a frequent denial driver, especially for bilateral or multi-level procedures.

Q: How do global periods affect billing for pain procedures?
Most interventional injections carry a 000-day global period, meaning the pre- and post-service work on the day of the procedure is bundled and a separate E/M on the same day generally isn't payable unless it's a significant, separately identifiable service supported by modifier 25. Some surgical implant procedures (for example, certain SCS work) carry longer global periods with specific post-op rules. Knowing the global period assigned to each code tells you when an office visit is separately billable and when it's already included.

Q: What's the right way to bill an E/M visit on the same day as an injection?
Only when there's a distinct, medically necessary evaluation beyond the routine assessment that any procedure requires. If a patient presents with a new problem, a change in condition, or a decision that requires a full work-up separate from the planned injection, an E/M with modifier 25 may be appropriate — but the documentation must stand on its own as a separately identifiable service. Reflexively appending modifier 25 to every procedure day is a well-known audit trigger, so the note, not the habit, should drive the billing.

Q: How should practices handle denials and underpayments on interventional claims?
Build a denial taxonomy and work it systematically. The recurring categories in pain are medical necessity (LCD frequency limits, missing conservative care), bundling/NCCI edits, authorization mismatches, and laterality/units errors. Track denials by reason code and payer, because patterns reveal whether the fix is documentation, a front-end auth process change, or a coding correction. For underpayments, compare paid amounts against your contracted fee schedule line by line — silent underpayment against the negotiated rate is common and only recoverable if you're auditing remittances.

Interventional Pain Management: A Practice-Management Q&A

CODING

Q: What are the core CPT code families in interventional pain?
The workhorses include epidural injections (the 62320–62327 range for cervical/thoracic and lumbar/sacral, transforaminal in the 64479–64484 range), facet joint and medial branch procedures (64490–64495 for injections and blocks, 64633–64636 for radiofrequency ablation), sacroiliac joint injections, sympathetic blocks, and the neurostimulator families (63650/63655/63661 63664 and 63685 for implantation and revision). Vertebral augmentation (kyphoplasty/vertebroplasty) and intrathecal pump procedures round out the higher-acuity end. Accurate coding depends on level, laterality, imaging guidance, and whether the service is a trial versus a permanent implant.

Q: Which modifiers are most consequential, and where do practices go wrong?
Modifier 50 (bilateral), the LT/RT laterality modifiers, modifier 59 and its X{EPSU} subsets (distinct procedural service), and modifier 25 (separate E/M) drive most of the modifier-related denials and audits. The common mistakes are billing bilateral procedures as two units instead of using modifier 50 where the payer requires it (or vice versa), overusing 59 to force payment through NCCI edits when the edit is actually valid, and appending 25 without supporting documentation. Payer rules on bilateral billing genuinely differ, so the same procedure may require modifier 50 for one plan and LT/RT units for another.

Q: How do NCCI edits and MUEs affect interventional coding?
National Correct Coding Initiative (NCCI) edits define which code pairs can't be billed together, and Medically Unlikely Edits (MUEs) cap the units of a code that will be paid on a single date. In pain, these matter constantly because multi-level and bilateral procedures push against unit limits, and image-guidance codes are frequently bundled into the primary procedure. Before overriding an edit with a modifier, confirm the two services were genuinely separate and distinct — the modifier documents a clinical reality, it doesn't create permission to unbundle.

Q: How should imaging guidance be coded with injections?
Fluoroscopic or CT guidance is bundled into many current injection codes rather than separately reportable, and billing a separate guidance code where it's already included is a frequent overpayment finding. The rule varies by the specific procedure code and year, so the safe practice is to check whether guidance is inclusive for each code you use rather than assuming it's always separately billable.

Q: What documentation elements make an interventional claim defensible?
At minimum: the specific level(s) and laterality treated, the indication tied to a supporting diagnosis, the conservative care already tried and failed, the imaging guidance used, medication and dosage, response or intended follow-up, and — for repeat procedures — the documented benefit from the prior injection (percentage and duration of relief). Payers increasingly require evidence that an earlier injection produced meaningful, sustained relief before they'll cover a repeat, so "worked well" isn't enough; quantify it.

COMPLIANCE

Q: What are the biggest compliance exposures specific to interventional pain?
Four stand out: medical-necessity documentation against LCD requirements (frequency limits and conservative-care prerequisites for injections), urine drug testing (UDT) practices, opioid prescribing and monitoring, and financial-relationship rules (Stark and Anti-Kickback) around ancillary services and referral arrangements. Pain management has drawn sustained OIG and payer attention precisely because it combines high-volume procedures, controlled substances, and frequent in-office ancillaries  the exact profile that invites audits.

Q: Why is urine drug testing such a compliance flashpoint, and how should it be handled?
UDT is legitimately part of responsible opioid management, but it's also been a source of significant enforcement actions where practices ordered blanket high-complexity confirmatory panels on every patient at every visit regardless of clinical need. Defensible UDT is individualized: presumptive versus definitive testing chosen for a documented clinical reason, frequency tied to the patient's risk stratification rather than a fixed protocol, and no financial incentive driving the volume. If the ordering pattern looks uniform across a panel of patients, expect scrutiny.

Q: How do Stark and the Anti-Kickback Statute apply to a pain practice?
Stark restricts physician referrals for designated health services to entities with which the physician has a financial relationship, unless an exception applies; the Anti-Kickback Statute (AKS) criminalizes remuneration intended to induce referrals for federally reimbursed services. In pain management these surface around in-office ancillary services, ownership in ASCs or imaging, arrangements with device or lab vendors, and marketing or "medical director" payments that don't reflect fair market value. The guardrails are fair-market-value compensation, arrangements documented in writing, and structures that fit recognized exceptions or safe harbors  not informal handshake deals.

Q: What LCD-driven rules trip up injection billing most often?
Frequency limitations and step-therapy prerequisites. Medicare contractors have tightened coverage for epidural steroid injections and facet interventions, commonly limiting the number of injections per anatomic region per year and requiring documented conservative care and quantified relief from prior injections before covering repeats. Practices get burned when they schedule on a fixed clinical cadence that outpaces what the LCD will actually cover, then absorb the denials. Aligning the treatment plan to the active LCD  and documenting the exceptions when clinically justified  is the fix.

CONTRACTING

Q: What should a pain practice focus on when negotiating payer contracts?
Look past the headline conversion factor to the specifics that actually determine yield: the fee schedule for your highest-volume CPT codes (not just the E/M rates), multiple-procedure reduction rules, bilateral and multi-level payment policies, the prior authorization requirements attached to the plan, and the timely-filing and appeal windows. Two contracts with identical "percent of Medicare" language can pay very differently once multiple-procedure logic and site-of-service differentials are applied to your actual case mix. Model proposed rates against your real procedure volume before signing.

Q: In-network versus out-of-network  how should a pain practice think about it?
In-network brings volume, predictable rates, and access to plan patients, but at negotiated (often discounted) rates and with the plan's utilization controls. Out-of-network can pay more per case but carries collection risk, balance-billing constraints (including No Surprises Act protections for many services), and patient friction. Most interventional practices operate primarily in-network for sustainable volume and reserve out-of-network strategy for specific plans or services where the economics and legal footing clearly support it.

Q: What are single case agreements (SCAs), and when do they apply?
An SCA is a one-off contract for a specific patient with a plan you're not contracted with, typically used when the patient needs care you provide and there's no adequate in-network option, or to complete an episode of care. They're negotiated case by case, so the rate, authorized services, and payment terms should be pinned down in writing before you deliver the service  verbal assurances from a plan rep are not a rate agreement.

Q: How does ASC contracting differ from professional-fee contracting?
They're separate negotiations with separate economics. The ASC facility contract covers the facility fee for the approved procedure list, often as a percentage of the Medicare ASC rate or a case-rate structure, and hinges on which procedures the ASC is credentialed and equipped to perform. The physician's professional-fee contract is distinct. A practice that owns or uses an ASC has to manage both, and has to be sure the arrangement between the two respects the financial-relationship rules discussed above.

CREDENTIALING

Q: What does the credentialing and enrollment sequence look like for a new pain physician?
The typical path: a complete and attested CAQH ProView profile, primary-source verification of licensure, DEA registration, board certification, education and training, then payer-by-payer enrollment (commercial plans plus Medicare via PECOS and Medicaid). Hospital and ASC privileging runs in parallel and has its own application and peer-review process. The whole cycle commonly takes 90–150 days per payer, so it should start well before the physician's expected start date  a provider who sees patients before enrollment is effective often can't bill for that early work.

Q: What's the difference between credentialing, enrollment, and privileging?
Credentialing is the verification of a provider's qualifications (license, training, board status, history). Enrollment is getting the provider loaded into a specific payer's network so claims can be paid. Privileging is a facility's decision to authorize a provider to perform specific procedures there, based on documented training and competency. A pain physician can be credentialed and enrolled but still unable to perform a given procedure at an ASC until privileged for it — and the privilege list should match the procedures the physician actually bills.

Q: How should re-credentialing and expirables be managed?
Payers re-credential on a cycle (often every three years), and expirables  license, DEA, board certification, malpractice coverage, CAQH re-attestation  lapse on their own schedules. A single tracking system with advance-warning alerts prevents the classic failure mode where a lapsed credential quietly turns a provider out-of-network mid-cycle and claims start denying. Keeping CAQH attested and current is especially important because many payers pull from it automatically.

Q: What credentialing issues are specific to interventional and ASC settings?
Procedure-specific privileging is the big one: implanting spinal cord stimulators, performing radiofrequency ablation, or doing vertebral augmentation typically requires documented case logs or proctoring, not just a license. ASCs and hospitals also credential for the specific equipment and techniques they support, and device manufacturers may have their own training requirements for certain implants. Line up the privileging and any manufacturer training before scheduling the first case, not after.

Mental Health & Behavioral Health Integration

Q: Why does behavioral health belong in an interventional pain practice at all?
Chronic pain is a biopsychosocial condition  depression, anxiety, catastrophizing, and sleep disruption both worsen pain and worsen procedural and surgical outcomes. Integrating behavioral health improves function, supports safer opioid management, and is increasingly expected by payers as part of a comprehensive treatment model. It's also a distinct, billable line of clinical service when delivered and documented properly, so it's both better medicine and a legitimate revenue stream rather than an unfunded add-on.

Q: What's the psychological evaluation requirement for spinal cord stimulator candidates?
A pre-implant psychological evaluation is a standard payer and clinical requirement before an SCS trial or permanent implant. It screens for untreated psychiatric conditions, unrealistic expectations, and psychosocial factors that predict poor outcomes, and it's frequently a documented prerequisite for coverage. Skipping or under-documenting it is a common reason SCS authorizations and claims are denied, so it should be built into the SCS pathway as a required, documented step  not an optional extra.

Q: How is integrated behavioral health billed in a pain setting?
Several distinct pathways exist. The Collaborative Care Model (CoCM) codes (99492–99494, plus 99484 for general behavioral health integration) support a psychiatric-consultant-and-care-manager model billed by the treating physician. Health Behavior Assessment and Intervention codes (96156, 96158–96159, 96164–96171) cover psychological services addressing a physical health condition like chronic pain  distinct from psychotherapy codes, which address a mental-health diagnosis. Choosing the right family depends on whether you're treating the psychological dimension of the pain condition or a separate psychiatric diagnosis, and the documentation has to match.

Q: What behavioral interventions have the strongest fit with interventional pain?
Cognitive behavioral therapy for chronic pain, acceptance and commitment therapy, biofeedback, and structured pain self management programs pair well with interventional care and are supported by the evidence base for improving function and reducing disability. Embedding these  whether through an in-house behavioral health clinician or a formal collaborative-care arrangement  lets the practice treat the whole condition rather than only its procedural targets, which also strengthens the medical-necessity narrative for the interventional side.

Q: What compliance considerations apply to behavioral health billing in pain?
The same medical-necessity and documentation discipline applies: the behavioral service must be distinct from the routine pre procedure assessment, tied to a supporting diagnosis, and documented with time and content where the code is time-based. Watch the line between health-behavior codes (physical-condition focus) and psychotherapy codes (mental-health-diagnosis focus), because billing the wrong family is a common error. And where a separate behavioral health provider is involved, the credentialing, supervision, and incident-to rules for that provider have to be respected. 

Ambulatory Surgery Centers (ASC)

Q: Which interventional pain procedures can move to an ASC?
Only procedures on the Medicare ASC-approved (covered procedures) list  and the equivalent lists for commercial payers — are payable in that setting. The list has expanded over time to include much of the interventional pain repertoire (many injections, RFA, some neurostimulator work, vertebral augmentation), but it's revised annually and not everything qualifies. Confirm a procedure's ASC-payable status for the current year and for each payer before building it into ASC scheduling, because a non-covered procedure performed in the ASC can leave the facility fee unpaid.

Q: How does ASC reimbursement compare to the hospital outpatient (HOPD) setting?
ASCs are generally reimbursed at a lower facility rate than HOPDs for the same procedure under Medicare, which is precisely why payers favor migrating appropriate cases to ASCs and why the site-of-service differential matters in contracting. For the practice, the ASC often improves the total economics of a case (efficiency, throughput, and, where ownership is compliant, facility revenue), but the per-case facility payment is set by the ASC fee schedule, not the HOPD rate.

Q: What accreditation and certification does a pain ASC need?
To bill Medicare, an ASC needs Medicare certification, achieved through the state survey process or deemed status via an approved accrediting organization (AAAHC, The Joint Commission, or others). Accreditation is also frequently required by commercial payers to contract. Beyond the initial certification, the ASC must maintain compliance with the Conditions for Coverage, including governance, quality assessment, infection control, and life-safety standards — this is an ongoing operational obligation, not a one-time hurdle.

Q: How does ASC quality reporting work?
Medicare-certified ASCs participate in the ASC Quality Reporting (ASCQR) Program, submitting specified measures to avoid a reduction in their annual payment update. The measure set evolves, so the compliance task is staying current on which measures are required for the reporting year and ensuring the data-collection workflow captures them accurately. Missing the reporting requirements has a direct financial consequence through the payment penalty.

Q: What are the key financial-relationship pitfalls when physicians own the ASC they use?
​Physician ownership in an ASC is permissible and common, but it has to fit within the recognized safe harbor and be structured with care  ownership returns tied to referrals, non-fair-market-value arrangements, or steering that isn't clinically driven all create Anti-Kickback exposure. The defensible structure has ownership returns proportional to investment (not to referral volume), transparent arrangements, and clinical decisions about site of service documented on their medical merits. Because the ASC facility fee and the physician's professional fee both flow from the same case, this is exactly the kind of arrangement enforcement bodies examine.

This Q&A is educational and does not constitute legal, coding, or reimbursement advice. Verify all codes, modifiers, coverage policies, and regulatory requirements against current-year CMS guidance, your MAC's active LCDs, and each payer's medical policy before applying them to billing or compliance decisions.

Miss Pinky Maniri is a National Speaker and Global Healthcare Operations Strategist, a Founder and CEO, and a recognized authority in revenue cycle leadership, AI governance, clinical documentation integrity, and specialty practice operations. As the founder of GoHealthcare Practice Solutions, GoHealthcare AI Solutions, Axendra Solutions, and Vaydah Healthcare, she has built a multi enterprise ecosystem that shapes operational excellence across the United States and internationally. With more than twenty years of experience guiding medical practices, healthcare organizations, global nurse workforce pipelines, and physician enterprises, she is widely regarded as a leading voice in predictive intelligence, compliance strategy, and C suite healthcare transformation.